UnitedHealth Group (UNH) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

UNH Stock Forecast


UnitedHealth Group stock forecast is as follows: an average price target of $577.00 (represents a -2.15% downside from UNH’s last price of $589.65) and a rating consensus of 'Buy', based on 32 wall street analysts offering a 1-year stock forecast.

UNH Price Target


The average price target for UnitedHealth Group (UNH) is $577.00 based on 1-year price targets from 32 Wall Street analysts in the past 3 months, with a price target range of $650.00 to $442.00. This represents a potential -2.15% downside from UNH's last price of $589.65.

UNH Analyst Ratings


Buy

According to 32 Wall Street analysts, UnitedHealth Group's rating consensus is 'Buy'. The analyst rating breakdown for UNH stock is 1 'Strong Buy' (3.13%), 26 'Buy' (81.25%), 3 'Hold' (9.38%), 2 'Sell' (6.25%), and 0 'Strong Sell' (0.00%).

UnitedHealth Group Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 16, 2024Ben HendrixRBC Capital$595.00$556.296.96%0.91%
Oct 16, 2024David MacDonaldTruist Financial$625.00$556.2912.35%6.00%
Oct 16, 2024Joanna GajukBank of America Securities$650.00$556.2916.85%10.23%
Oct 16, 2024David WindleyJefferies$643.00$556.2915.59%9.05%
Oct 16, 2024George HillDeutsche Bank$595.00$556.296.96%0.91%
Oct 16, 2024Matthew GillmorKeyBanc$650.00$569.6614.10%10.23%
Oct 10, 2024Matthew GillmorKeyBanc$675.00$597.7012.93%14.47%
Jul 17, 2024David ToungArgus Research$600.00$565.786.05%1.76%
Jul 17, 2024David MacDonaldTruist Financial$640.00$548.8716.60%8.54%
Jul 17, 2024Scott FidelStephens$600.00$548.879.32%1.76%
Row per page
Go to

The latest UnitedHealth Group stock forecast, released on Oct 16, 2024 by Ben Hendrix from RBC Capital, set a price target of $595.00, which represents a 6.96% increase from the stock price at the time of the forecast ($556.29), and a 0.91% increase from UNH last price ($589.65).

UnitedHealth Group Price Target by Period


1M3M12M
# Anlaysts-719
Avg Price Target-$633.29$595.95
Last Closing Price$589.65$589.65$589.65
Upside/Downside-100.00%7.40%1.07%

In the current month, the average price target of UnitedHealth Group stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to UnitedHealth Group's last price of $589.65. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Oct 22, 2024UBSBuyBuyHold
Oct 17, 2024HSBCBuyHoldDowngrade
Oct 16, 2024Cantor FitzgeraldOverweightOverweightHold
Oct 16, 2024RBC CapitalOutperformOutperformHold
Oct 16, 2024StephensOverweightOverweightHold
Oct 16, 2024JefferiesBuyBuyHold
Oct 16, 2024Deutsche BankBuyBuyHold
Oct 16, 2024KeyBancOverweightOverweightHold
Oct 11, 2024Wells FargoBuyBuyHold
Oct 11, 2024Cowen & Co.BuyBuyHold
Row per page
Go to

UnitedHealth Group's last stock rating was published by UBS on Oct 22, 2024. The company gave UNH a "Buy" rating, the same as its previous rate.

UnitedHealth Group Financial Forecast


UnitedHealth Group Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue-------------$92.36B$91.79B$91.13B$81.93B$80.38B$80.04B$79.78B$72.93B$71.83B$70.77B$69.74B$65.02B$64.76B$61.80B$64.06B$60.47B$59.88B
Avg Forecast$118.61B$116.48B$116.10B$115.34B$109.44B$107.84B$107.04B$106.32B$101.54B$99.14B$98.79B$99.23B$92.13B$91.41B$90.97B$89.71B$82.48B$80.52B$79.68B$78.73B$72.98B$71.38B$69.51B$69.07B$64.96B$63.79B$63.48B$64.16B$60.96B$59.76B
High Forecast$121.19B$119.01B$118.62B$117.84B$111.81B$110.18B$109.37B$108.52B$103.97B$99.19B$98.79B$99.23B$93.44B$93.40B$92.94B$91.65B$84.27B$82.32B$81.45B$80.48B$74.61B$72.97B$71.05B$70.61B$66.41B$65.21B$64.90B$65.59B$62.31B$61.09B
Low Forecast$116.58B$114.49B$114.12B$113.37B$107.57B$105.99B$105.21B$103.89B$99.64B$99.09B$98.79B$99.23B$90.78B$89.85B$89.41B$88.17B$81.07B$78.98B$78.15B$77.22B$71.58B$70.01B$68.17B$67.75B$63.72B$62.57B$62.27B$62.94B$59.79B$58.62B
# Analysts9999888101376612999555566667871096
Surprise %-------------1.01%1.01%1.02%0.99%1.00%1.00%1.01%1.00%1.01%1.02%1.01%1.00%1.02%0.97%1.00%0.99%1.00%

UnitedHealth Group's average Quarter revenue forecast for Dec 23 based on 12 analysts is $92.13B, with a low forecast of $90.78B, and a high forecast of $93.44B. UNH's average Quarter revenue forecast represents a -0.25% decrease compared to the company's last Quarter revenue of $92.36B (Sep 23).

UnitedHealth Group EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts9999888101376612999555566667871096
EBITDA-------------$9.53B$7.96B$8.26B$7.02B$7.78B$7.64B$7.37B$6.19B$6.40B$6.65B$7.38B$4.11B$5.29B$9.90B$5.64B$5.69B$5.63B
Avg Forecast$11.46B$11.25B$11.21B$11.14B$10.57B$10.42B$10.34B$10.27B$9.81B$9.58B$9.54B$9.03B$8.90B$8.83B$8.79B$8.21B$6.53B$7.29B$7.21B$7.46B$6.61B$6.46B$6.29B$5.81B$5.88B$5.77B$5.75B$5.50B$5.52B$5.41B
High Forecast$11.71B$11.50B$11.46B$11.38B$10.80B$10.64B$10.56B$10.48B$10.04B$9.58B$9.54B$10.83B$9.03B$9.02B$8.98B$9.85B$7.83B$7.45B$7.37B$8.95B$6.75B$6.61B$6.43B$6.98B$6.01B$5.90B$5.87B$6.60B$5.64B$5.53B
Low Forecast$11.26B$11.06B$11.02B$10.95B$10.39B$10.24B$10.16B$10.04B$9.62B$9.57B$9.54B$7.22B$8.77B$8.68B$8.64B$6.57B$5.22B$7.15B$7.07B$5.97B$6.48B$6.34B$6.17B$4.65B$5.77B$5.66B$5.64B$4.40B$5.41B$5.31B
Surprise %-------------1.08%0.91%1.01%1.08%1.07%1.06%0.99%0.94%0.99%1.06%1.27%0.70%0.92%1.72%1.03%1.03%1.04%

12 analysts predict UNH's average Quarter EBITDA for Dec 23 to be $8.90B, with a high of $9.03B and a low of $8.77B. This is -6.65% lower than UnitedHealth Group's previous annual EBITDA (Sep 23) of $9.53B.

UnitedHealth Group Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts9999888101376612999555566667871096
Net Income-------------$5.84B$5.47B$5.61B$4.76B$5.26B$5.07B$5.03B$4.19B$4.09B$4.27B$4.86B$2.21B$3.17B$6.64B$3.38B$3.54B$3.54B
Avg Forecast$7.43B$8.11B$7.72B$7.98B$6.84B$7.23B$6.87B$6.90B$6.28B$6.51B$6.18B$5.96B$5.57B$5.89B$5.57B$5.42B$4.29B$5.05B$4.84B$4.92B$4.00B$4.11B$4.12B$3.83B$2.24B$2.89B$4.91B$3.30B$3.51B$3.48B
High Forecast$7.64B$8.34B$7.94B$8.21B$7.03B$7.43B$7.07B$7.40B$6.46B$6.54B$6.18B$7.15B$5.60B$6.06B$5.73B$6.50B$5.15B$5.20B$4.98B$5.91B$4.12B$4.23B$4.24B$4.60B$2.30B$2.97B$5.05B$3.96B$3.61B$3.59B
Low Forecast$7.27B$7.93B$7.55B$7.81B$6.69B$7.07B$6.72B$6.45B$6.01B$6.49B$6.18B$4.77B$5.49B$5.76B$5.45B$4.33B$3.43B$4.92B$4.72B$3.94B$3.90B$4.00B$4.02B$3.06B$2.18B$2.82B$4.78B$2.64B$3.42B$3.40B
Surprise %-------------0.99%0.98%1.04%1.11%1.04%1.05%1.02%1.05%1.00%1.03%1.27%0.99%1.10%1.35%1.03%1.01%1.02%

UnitedHealth Group's average Quarter net income forecast for Dec 23 is $5.57B, with a range of $5.49B to $5.60B. UNH's average Quarter net income forecast represents a -4.71% decrease compared to the company's last Quarter net income of $5.84B (Sep 23).

UnitedHealth Group SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts9999888101376612999555566667871096
SG&A------------------------------
Avg Forecast$3.49B$3.42B$3.41B$3.39B$3.22B$3.17B$3.15B$3.13B$2.99B$2.91B$2.90B$2.92B$2.71B$2.69B$2.67B$2.64B$2.42B$12.15B$12.03B$11.88B$11.02B$10.77B$10.49B$10.43B$9.81B$9.63B$9.58B$9.68B$9.20B$9.02B
High Forecast$3.56B$3.50B$3.49B$3.46B$3.29B$3.24B$3.22B$3.19B$3.06B$2.92B$2.90B$2.92B$2.75B$2.75B$2.73B$2.69B$2.48B$12.42B$12.29B$12.15B$11.26B$11.01B$10.72B$10.66B$10.02B$9.84B$9.80B$9.90B$9.41B$9.22B
Low Forecast$3.43B$3.37B$3.35B$3.33B$3.16B$3.12B$3.09B$3.05B$2.93B$2.91B$2.90B$2.92B$2.67B$2.64B$2.63B$2.59B$2.38B$11.92B$11.80B$11.66B$10.80B$10.57B$10.29B$10.23B$9.62B$9.44B$9.40B$9.50B$9.02B$8.85B
Surprise %------------------------------

UnitedHealth Group's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to UNH last annual SG&A of $NaN (undefined).

UnitedHealth Group EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts9999888101376612999555566667871096
EPS-------------$6.31$5.88$6.01$5.10$5.63$5.41$5.34$4.45$4.34$4.52$5.15$2.34$3.34$6.99$3.57$3.74$3.74
Avg Forecast$7.99$8.72$8.30$8.58$7.35$7.77$7.39$7.42$6.75$7.01$6.65$6.61$5.98$6.33$5.99$6.16$5.17$5.43$5.21$5.37$4.31$4.42$4.43$4.39$2.41$3.11$5.28$3.63$3.78$3.75
High Forecast$8.22$8.97$8.53$8.83$7.56$7.99$7.60$7.95$6.94$7.04$6.65$6.61$6.02$6.51$6.16$6.34$5.32$5.59$5.36$5.53$4.43$4.54$4.56$4.52$2.48$3.20$5.43$3.73$3.89$3.86
Low Forecast$7.81$8.53$8.12$8.39$7.19$7.60$7.23$6.93$6.46$6.97$6.65$6.61$5.90$6.19$5.86$6.03$5.06$5.29$5.08$5.24$4.20$4.31$4.32$4.28$2.35$3.03$5.14$3.54$3.68$3.65
Surprise %-------------1.00%0.98%0.98%0.99%1.04%1.04%0.99%1.03%0.98%1.02%1.17%0.97%1.08%1.32%0.98%0.99%1.00%

According to 12 Wall Street analysts, UnitedHealth Group's projected average Quarter EPS for Dec 23 is $5.98, with a low estimate of $5.90 and a high estimate of $6.02. This represents a -5.16% decrease compared to UNH previous annual EPS of $6.31 (Sep 23).

UnitedHealth Group Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
CVSCVS Health$56.05$98.5075.74%Buy
HUMHumana$271.35$445.8664.31%Hold
CNCCentene$58.83$92.2056.72%Buy
ELVElevance Health$400.70$538.7434.45%Buy
MOHMolina Healthcare$292.19$349.3819.57%Hold
CICigna$322.45$318.74-1.15%Buy
UNHUnitedHealth Group$589.65$577.00-2.15%Buy
ALHCAlignment Healthcare$11.17$9.50-14.95%Buy

UNH Forecast FAQ


Is UnitedHealth Group a good buy?

Yes, according to 32 Wall Street analysts, UnitedHealth Group (UNH) is considered a 'Buy'. The rating consensus is based on 1 'Strong Buy' and 26 'Buy' recommendations, accounting for 84.38% of UNH's total ratings.

What is UNH's price target?

UnitedHealth Group (UNH) average price target is $577 with a range of $442 to $650, implying a -2.15% from its last price of $589.65. The data is based on 32 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will UnitedHealth Group stock go up soon?

According to Wall Street analysts' prediction for UNH stock, the company can go down by -2.15% (from the last price of $589.65 to the average price target of $577), up by 10.23% based on the highest stock price target, and down by -25.04% based on the lowest stock price target.

Can UnitedHealth Group stock reach $900?

UNH's average twelve months analyst stock price target of $577 does not support the claim that UnitedHealth Group can reach $900 in the near future.

What are UnitedHealth Group's analysts' financial forecasts?

UnitedHealth Group's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $430.64B (high $439.88B, low $422.66B), average EBITDA is $41.6B (high $42.49B, low $40.83B), average net income is $27.84B (high $28.92B, low $26.92B), average SG&A $12.66B (high $12.93B, low $12.43B), and average EPS is $29.93 (high $31.1, low $28.95). UNH's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $466.54B (high $476.66B, low $458.55B), average EBITDA is $45.06B (high $46.04B, low $44.29B), average net income is $31.25B (high $32.13B, low $30.55B), average SG&A $13.72B (high $14.01B, low $13.48B), and average EPS is $33.6 (high $34.55, low $32.85).

Did the UNH's actual financial results beat the analysts' financial forecasts?

Based on UnitedHealth Group's last annual report (Dec 2022), the company's revenue was $322.13B, beating the average analysts forecast of $321.41B by 0.22%. Apple's EBITDA was $29.8B, beating the average prediction of $28.49B by 4.62%. The company's net income was $20.12B, beating the average estimation of $19.11B by 5.31%. Apple's SG&A was $0, missing the average forecast of $38.49B by -100.00%. Lastly, the company's EPS was $21.47, beating the average prediction of $21.18 by 1.37%. In terms of the last quarterly report (Sep 2023), UnitedHealth Group's revenue was $92.36B, beating the average analysts' forecast of $91.41B by 1.04%. The company's EBITDA was $9.53B, beating the average prediction of $8.83B by 7.96%. UnitedHealth Group's net income was $5.84B, missing the average estimation of $5.89B by -0.84%. The company's SG&A was $0, missing the average forecast of $2.69B by -100.00%. Lastly, the company's EPS was $6.31, missing the average prediction of $6.33 by -0.38%